Troika Labs · Accelerator & venture studio

We back whatshouldn’t existyet.

Deep-tech founders building step-changes, not increments. We carry you from lab result to signed pilot to Series A.

Health & life sciencesModern warfareRoboticsQuantum
Apply to Troika Labs → London · Cambridge · Mumbai

01 — Thesis

Incremental is crowded. The returns live where the risk is.

We back founders building something genuinely new — never the tenth version of something known.

i.

Consensus ideas raise fast — and are priced to perfection before they ship.

ii.

Hard science scares generalist capital. That fear is our opening.

iii.

We take the technical risk others won’t — then remove it, one milestone at a time.

02 — Discipline

What we don’t back.

If it can be built without deep science, someone cheaper will build it — faster.

03 — Where we hunt

Four frontiers. One test: does it change the category?

01

Health & life sciences

Clinical AI, diagnostics and computational biology that change what medicine can do.

02

Modern warfare

Autonomy, ISR, electronic warfare and decision AI — for a world where deterrence is written in software.

03

Robotics & physical AI

Perception, manipulation and edge compute that leave the lab for the ward, the plant and the field.

04

Quantum

Computing, sensing and secure communications — the next platform shift, built here.

04 — The ecosystem around us

The frontier is drawn in London and Cambridge.

We sit inside two of the densest clusters of frontier science on earth. This is the world on our doorstep.

London

AI · Defence · Bio
  • Frontier AI labsWhere the world’s leading models are built
  • AI-first drug discoveryModels that design medicines
  • Embodied AIAutonomy leaving the lab for the road
  • Defence softwareSynthetic battlespace and decision AI
  • National AI instituteResearch, policy and talent
  • World-class universitiesTalent pipelines in AI, engineering and medicine

Cambridge

Chips · Quantum · Defence
  • Chip designThe architecture inside most of the world’s phones
  • Quantum computingHardware and error correction
  • GenomicsSequencing at global scale
  • Defence hardwareLow-cost interceptors and autonomy
  • Life-science R&DGlobal pharma and biotech labs
  • University of CambridgeOur research partner

05 — The UK’s pattern

Invented here. Scaled elsewhere.

For seventy years, breakthroughs born in London and Cambridge have been scaled — and owned — somewhere else.

1953The structure of DNACambridgeThe foundation of modern biotech
1975Monoclonal antibodiesCambridgeA global antibody-drug industry
1990The world’s dominant chip architectureCambridgeListed in New York
1998Next-generation DNA sequencingCambridgeAcquired by a US genomics leader
2010A frontier AI labLondonAcquired by a US tech giant
2013AI for cyber defenceCambridgeTaken private by US capital
2018AI that solved protein foldingLondonNobel Prize in Chemistry, 2024

Troika sits at the source — and builds the company before the value leaves.

Breakthroughs from the UK ecosystem. Not Troika portfolio companies.

06 — The gap

The valley between science and scale.

CAPITAL ACCESS ↑ VALLEY OF DEATH THE TROIKA BRIDGE LABPROTOTYPEPILOTREVENUESERIES A

Grants and seed fund the science. Series A funds the scale.

In between: no product polish, no pilot, no buyer. It’s where most deep-tech companies stall — and exactly where Troika works.

07 — The model

Six moves from lab bench to Series A.

Space & infra

01

Labs, compute and a London base

Strategy

02

Partner-level guidance from day one

AI product studio

03

Designers and engineers inside your team

Corporate access

04

Introductions to Tier 1 companies in each sector

Pilots

05

Designed, measured, referenceable

Showcase & raise

06

Buyers and investors in one room

08 — What founders get

Much more than a desk and a demo day.

Strategic guidance

A partner in the room, not a mentor rota.

  • IP strategy and freedom to operate
  • Pricing: who pays, how much, from which budget
  • The story a Series A partner can retell in their IC
  • The first senior hires that bend the curve
AI product studio · London & Cambridge

A prototype is not a product.

Our designers and ML engineers work inside your sprint, with direct access to University of Cambridge researchers.

  • Design tested with daily users, not just buyers
  • Validated, monitored, deployable models
  • Evidence that survives scrutiny
Corporate access

Introductions to Tier 1 companies in each sector.

  • Health & life sciences leaders
  • Defence primes and sovereign buyers
  • Global manufacturers, chipmakers and hyperscalers
  • Tier-one VCs, CVCs and sovereign funds
Pilots & showcase

Proof a buyer can sign and a VC can price.

  • Design — metrics agreed with the buyer upfront
  • Run — our team on site with yours
  • Measure — outcomes against baseline
  • Showcase — buyers first, investors second

09 — Principles

How we build.

Six rules we hold ourselves to, with every company, in every sector.

PrincipleWhat it means in practiceFor founders
Step-change or nothingWe back new categories, not better versions of old onesA partner who wants you to be bold
Create, don’t just selectWe build alongside you from first principlesHands on the work, not just a cheque
Speed as a disciplineTight cadence, weekly milestones, fast decisionsMonths saved on the road to a pilot
Talent firstWe back exceptional people before the idea is finishedRoom to find the right problem
Proximity without captureClose to Tier 1 companies, owned by none of themAccess with your independence intact
Dual-use from day oneTechnology built for civil and defence marketsMore buyers, more routes to scale

10 — Portfolio

Built here.

Clinical AI · Choppr

Quandle Labs

Clinical-AI decisioning, developed in collaboration with Cleveland Clinic.

AI · Berkeley Fintech

Kronos AI

AI-native wealth management — the studio’s product engine applied beyond healthcare.

Healthcare · Dental

Neural Hive

AI software for clear dental aligners.

EdTech · AI training

SkillNova

An adaptive, self-learning and hybrid AI training platform for schools, universities and companies.

Engineering AI · CAE

Xsolve

AI surrogate models that predict simulation results in minutes, before the solver runs.

11 — For co-investors

What arrives at your Series A.

01

A product in market

Live with users — not a prototype waiting for a pilot.

02

Pilot data, named buyer

Outcomes measured against an agreed baseline.

03

A reference customer

Someone senior who will take your diligence call.

04

A clean company

Tidy cap table, IP assigned, path to market mapped.

12 — The window

Someone will build it. Make sure it’s you.

Apply now →
Or write to apply@troikalabs.uk